Sinopharm SHTDY Stock
Sinopharm Price Chart
Sinopharm SHTDY Financial and Trading Overview
| Sinopharm stock price | 9.75 USD |
| Previous Close | 9.82 USD |
| Open | 9.82 USD |
| Bid | 9.81 USD x 30000 |
| Ask | 9.93 USD x 343400 |
| Day's Range | 9.75 - 10.35 USD |
| 52 Week Range | 9 - 14.87 USD |
| Volume | 33.76K USD |
| Avg. Volume | 165.11K USD |
| Market Cap | 6.09B USD |
| Beta (5Y Monthly) | 0.456 |
| PE Ratio (TTM) | 6.0185184 |
| EPS (TTM) | 1.62 USD |
| Forward Dividend & Yield | 0.5 (5.14%) |
| Ex-Dividend Date | June 24, 2026 |
| 1y Target Est | N/A |
SHTDY Valuation Measures
| Enterprise Value | 107.5B USD |
| Trailing P/E | 6.0185184 |
| Forward P/E | N/A |
| PEG Ratio (5 yr expected) | 2.26 |
| Price/Sales (ttm) | 0.010581081 |
| Price/Book (mrq) | 0.47701412 |
| Enterprise Value/Revenue | 0.187 |
| Enterprise Value/EBITDA | 5.608 |
Trading Information
Sinopharm Stock Price History
| Beta (5Y Monthly) | 0.456 |
| 52-Week Change | -21.84% |
| S&P500 52-Week Change | 10.88% |
| 52 Week High | 14.87 USD |
| 52 Week Low | 9 USD |
| 50-Day Moving Average | 9.81 USD |
| 200-Day Moving Average | 11.56 USD |
SHTDY Share Statistics
| Avg. Volume (3 month) | 165.11K USD |
| Avg. Daily Volume (10-Days) | 228.53K USD |
| Shares Outstanding | 268.36M |
| Float | 254.92M |
| Short Ratio | N/A |
| % Held by Insiders | 0% |
| % Held by Institutions | 0% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | 437.00% |
| Payout Ratio | 0.3067 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2025 |
| Most Recent Quarter (mrq) | September 30, 2026 |
| Next Fiscal Year End | December 31, 2026 |
Profitability
| Profit Margin | 1.24% |
| Operating Margin (ttm) | 2.62% |
| Gross Margin | 7.24% |
| EBITDA Margin | 3.33% |
Management Effectiveness
| Return on Assets (ttm) | N/A |
| Return on Equity (ttm) | N/A |
Income Statement
| Revenue (ttm) | 575.11B USD |
| Revenue Per Share (ttm) | 922.15 USD |
| Quarterly Revenue Growth (yoy) | -87.099% |
| Gross Profit (ttm) | 41.67B USD |
| EBITDA | 19.17B USD |
| Net Income Avi to Common (ttm) | 7.15B USD |
| Diluted EPS (ttm) | 1.62 |
| Quarterly Earnings Growth (yoy) | -81.20% |
Balance Sheet
| Total Cash (mrq) | 31.04B USD |
| Total Cash Per Share (mrq) | 49.74 USD |
| Total Debt (mrq) | 81.32B USD |
| Total Debt/Equity (mrq) | 59.64 USD |
| Current Ratio (mrq) | N/A |
| Book Value Per Share (mrq) | 20.439646 |
Cash Flow Statement
| Operating Cash Flow (ttm) | N/A |
| Levered Free Cash Flow (ttm) | N/A |
Profile of Sinopharm
| Country | United States |
| State | N/A |
| City | Shanghai |
| Address | Sinopharm Group Building |
| ZIP | 200023 |
| Phone | 86 21 2305 2666 |
| Website | https://www.sinopharmgroup.com.cn |
| Industry | Medical Distribution |
| Sector(s) | Healthcare |
| Full Time Employees | 94910 |
Sinopharm Group Co. Ltd., together with its subsidiaries, engages in the wholesale and retail of pharmaceutical and healthcare products, and medical devices in the People's Republic of China. The company operates through four segments: Pharmaceutical Distribution, Medical Devices Distribution, Retail Pharmacy, and Other Business. The Pharmaceutical Distribution segment distributes pharmaceutical products to hospitals, other distributors, retail pharmacy stores, and clinics. This segment also offers distribution, logistics, and other value-added services for domestic and international pharmaceutical and healthcare products manufacturers, and other suppliers. The Medical Devices Distribution segment distributes medical devices, as well as provides installation and maintenance services. The Retail Pharmacy segment operates and franchises a network of retail drug stores. The Other Business segment engages in the distribution of laboratory supplies; manufacture and distribution of chemical reagents; and production and sale of pharmaceutical products. The company rents and manages properties; distributes medical instruments and equipment, Chinese herbal medicines, antibiotics, and biological products; and offers information technology, investment, goods and technology import and export, business consulting, health consultation, medical consulting, market information consulting and investigation, and convention and exhibition services. It also manages medical project investment, consulting, and technology training activities; and manufactures medicines. Sinopharm Group Co. Ltd. was founded in 2003 and is headquartered in Shanghai, the People's Republic of China. Sinopharm Group Co. Ltd. is a subsidiary of Sinopharm Industrial Investment Co., Ltd.
Q&A For Sinopharm Stock
What is a current SHTDY stock price?
Sinopharm SHTDY stock price today per share is 9.75 USD.
How to purchase Sinopharm stock?
You can buy SHTDY shares on the OTC Markets OTCPK exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Sinopharm?
The stock symbol or ticker of Sinopharm is SHTDY.
Which industry does the Sinopharm company belong to?
The Sinopharm industry is Medical Distribution.
How many shares does Sinopharm have in circulation?
The max supply of Sinopharm shares is 624.13M.
What is Sinopharm Price to Earnings Ratio (PE Ratio)?
Sinopharm PE Ratio is 6.01851840 now.
What was Sinopharm earnings per share over the trailing 12 months (TTM)?
Sinopharm EPS is 1.62 USD over the trailing 12 months.
Which sector does the Sinopharm company belong to?
The Sinopharm sector is Healthcare.
